Evidence map›Paper›PMID 32144694›Full record

ArticleJournal of general internal medicine2020

An Effectiveness Evaluation of a Primary Care-Embedded Clinical Pharmacist-Led Intervention Among Blacks with Diabetes.

Kimberly Danae Cauley Narain, Danielle Doppee, Ning Li, Gerardo Moreno, Douglas S Bell, Amanda L Do, Robert W Follett, Carol M Mangione

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kimberly Danae Cauley NarainDepartment of Medicine, Division of General Internal Medicine and Health Services Research (GIM/HSR), University of California, Los Angeles, Los Angeles, CA, 90024, USA. KNarain@mednet.ucla.edu.ORCID 0000-0001-8548-1728
Danielle DoppeeDepartment of Medicine, Division of General Internal Medicine and Health Services Research (GIM/HSR), University of California, Los Angeles, Los Angeles, CA, 90024, USA.
Ning LiDepartment of Medicine, Division of General Internal Medicine and Health Services Research (GIM/HSR), University of California, Los Angeles, Los Angeles, CA, 90024, USA.
Gerardo MorenoDepartment of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Douglas S BellDepartment of Medicine, Division of General Internal Medicine and Health Services Research (GIM/HSR), University of California, Los Angeles, Los Angeles, CA, 90024, USA.
Amanda L DoClinical and Translational Science Institute, University of California, Los Angeles, Los Angeles, CA, USA.
Robert W FollettClinical and Translational Science Institute, University of California, Los Angeles, Los Angeles, CA, USA.
Carol M MangioneDepartment of Medicine, Division of General Internal Medicine and Health Services Research (GIM/HSR), University of California, Los Angeles, Los Angeles, CA, 90024, USA.
University of California, Los Angeles · USLos Angeles County Department of Health Services · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAROL M MANGIONE · 2002 to 2026
$19.7M
Health IT decision support to improve medication management safety and qualityK23AG042961 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MORENO, GERARDO · 2012 to 2016
$699k
NCATS NIH HHS UL1 TR001881NIA NIH HHS K23 AG042961NIA NIH HHS P30 AG021684NIH HHS P30AG021684NIH HHS UL1TR001881
6 · The paper itself

Abstract

backgroundBlack individuals with type 2 diabetes suffer disproportionate morbidity and mortality relative to whites with type 2 diabetes, irrespective of health insurance coverage.

objectiveExamine the impact of a primary care-embedded clinical pharmacist-led intervention (UCMyRx) on cardiovascular risk factor control among blacks with type 2 diabetes in a large healthcare system.

designWe used data extracted from the electronic health records (EHR) system and a difference-in-differences study design with a propensity-matched comparison group to evaluate the impact of UCMyRx on HbA1c and systolic blood pressure (SBP) among black patients with type 2 diabetes, relative to usual care.

participantsIndividuals with type 2 diabetes identified as either black or African American in the EHR that were ≥ 18 years of age that had the following observations during the study window (03/02/2013-12/31/18: (1) HbA1C ≥ 8%, at least once, anywhere between 365 days before and 14 days after the UCMyRx visit and a follow-up HbA1c measure within 120 to 365 days after the visit and/or (2) SBP ≥ 140 mmHg at least once between 365 days before and 14 days after the UCMyRx visit that had a follow-up SBP measure within 120 to 450 days after the visit.

interventionUCMyRx pharmacists review labs and vital signs, perform medication reconciliation, use a standardized survey to assess barriers to medication adherence, and develop tailored interventions to improve medication adherence. MAIN MEASURES: Change in HbA1c and change in SBP from before to after the first UCMyRx visit. KEY

resultsHaving at least one visit with a UCMyRx clinical pharmacist was associated with a significant reduction in HbA1c (- 0.4%, p value = .01); however, there was no significant impact on SBP (- .051 mmHg, p value = 0.74).

conclusionsThe UCMyRx intervention is a useful strategy for improving HbA1c control among blacks with type 2 diabetes.

Indexed as

Diabetes Mellitus, Type 2PharmacistsBlack or African AmericanHumansMedication AdherencePrimary Health Carediabetesintervention“medication adherence”pharmacist“quality of care”“racial disparities”

Identifiers

PMID32144694
PMCPMC7458955
OpenAlexW3010164216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.